PLx Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview

PLx Pharma Winddown

09/11/2022 14:03

* PLx Pharma Inc  PLXP.OQ   PLXP.O  is expected to show a
fall in
quarterly revenue when it reports  results on November 11. 
    * The Sparta New Jersey-based  company is expected to report
 a
80.4% decrease in revenue to $1.3 million from $6.62 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for PLx Pharma Inc is
for a
loss of 44 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PLx Pharma
Inc is
$11​, above​ its last closing price of $0.60. ​​​

This summary was machine generated November 9 at 14:03 GMT.  All
figures in US dollars  unless otherwise stated